Karen Collica
Nurse Practitioner · San Diego, CANPI 1245673581
Payments from drug & device makers
Across 212 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$899
- Alkermes, Inc.$692
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$669
- Indivior Inc.$537
- Otsuka America Pharmaceutical, Inc.$513
- Neurocrine Biosciences, Inc.$366
- plus $1K from 7 others
What the payments were for
- Food & beverage$4,59298%
- Education$1132%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 27 | $899 |
| Alkermes, Inc. | 45 | $692 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $669 |
| Indivior Inc. | 23 | $537 |
| Otsuka America Pharmaceutical, Inc. | 26 | $513 |
| Neurocrine Biosciences, Inc. | 15 | $366 |
| Vanda Pharmaceuticals Inc. | 22 | $336 |
| Teva Pharmaceuticals USA, Inc. | 14 | $332 |
| E.r. Squibb & Sons, L.L.C. | 1 | $121 |
| Janssen Scientific Affairs, LLC | 1 | $114 |
| Lundbeck LLC | 5 | $85 |
| Tempus AI, Inc | 1 | $25 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$404
- CAPLYTA$141
- COBENFY$121
How this compares
$4,705 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 33 | $107,835 |
| CaplytaLumateperone Tosylate | 51 | $94,687 |
| IngrezzaValbenazine Tosylate | 12 | $90,888 |
| Abilify MaintenaAripiprazole | 20 | $53,873 |
| PerserisRisperidone | 12 | $32,671 |
| VivitrolNaltrexone Microspheres | 12 | $18,591 |
| Mirtazapine | 71 | $1,021 |
| Quetiapine Fumarate | 39 | $963 |
| Bupropion XlBupropion Hcl | 54 | $908 |
| Aripiprazole | 51 | $839 |
| Olanzapine | 52 | $726 |
| Haloperidol | 26 | $542 |
| Prazosin Hcl | 34 | $532 |
| Duloxetine Hcl | 17 | $435 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $374 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $899 | $107,83533 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $669 | $94,68751 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $366 | $90,88812 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $513 | $53,87320 claims |
| Indivior Inc.Perseris | $537 | $32,67112 claims |
| Alkermes, Inc.Vivitrol | $692 | $18,59112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in San Diego
- Angelina CollinsSan Diego$356K
- Madison ShreeveSan Diego$310K
- Arlene OrtegaSan Diego$135K
- Stacey RossSan Diego$43K
- Timothy LazarekSan Diego$37K
- Melanie McGillowaySan Diego$33K
- Jeremy FlowersSan Diego$26K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.